Stock EQL EQL PHARMA AB
Add to a list
To use this feature you must be a member
Log inSign up

Company EQL Pharma AB

Equities

EQL

SE0005497732

Drug Retailers

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 06:00:00 2024-04-25 pm EDT 		5-day change 1st Jan Change
43.3 SEK +0.70% Intraday chart for EQL Pharma AB +1.41% +29.64%
Apr. 22 EQL Pharma AB Announces Mellozzan Launched in Germany and Austria CI
Feb. 13 EQL Pharma AB Provides Sales Guidance for the Year 2023/24 CI

Business Summary

EQL Pharma AB is a Sweden-based Company that operates as a generic drugs and specialty pharmaceutical company. The Company engages in marketing, distributing, and selling generic drugs and specialty pharmaceuticals. Its main products are Anastrozol, Venlafaxin, Carvedilol, Metformin, Sumatriptan, Mometason, Glepark, among others. The company operates in Sweden and in Scandinavia.

Number of employees: 19

Sales per Business

SEK in Million2022Weight2023Weight Delta
Drug
78.4 %
135 33.0 % 204 78.4 % +50.55%
One-off Nature
21.6 %
274 67.0 % 56 21.6 % -79.54%

Sales per region

SEK in Million2022Weight2023Weight Delta
Sweden
62.6 %
410 100.0 % 163 62.6 % -60.28%
Scandinavia
28.5 %
-- 74 28.5 % -
Rest of Europe
8.9 %
-- 23 8.9 % -

Managers

Managers TitleAgeSince
Axel Schörling CEO
 Chief Executive Officer 38 18-01-31
Lars Christer Fedrik Fåhraeus FOU
 Founder 59 05-12-31
Anna Jönsson DFI
 Director of Finance/CFO 40 21-12-14
Martin Kristofferson COO
 Chief Operating Officer 46 -
Alexander Brising PRN
 Corporate Officer/Principal 54 16-10-31

Members of the board

Members of the board TitleAgeSince
Lars Christer Fedrik Fåhraeus FOU
 Founder 59 05-12-31
Rajiv Indravadan Modi BRD
 Director/Board Member 63 14-12-31
Ingrid Linda Marie Neckmar BRD
 Director/Board Member 51 19-12-31
Per Svangren BRD
 Director/Board Member 51 20-12-31
Per Ollermark BRD
 Director/Board Member - -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,063,610 29,063,610 ( 100.00 %) 0 100.00 %

Shareholders

NameEquities%Valuation
Rajiv Indravadan Modi
30.00 %
8,718,500 30.00 % 34 M kr
Lars Christer Fedrik Fåhraeus
29.00 %
8,427,348 29.00 % 33 M kr
SEB Investment Management AB
2.190 %
636,493 2.190 % 3 M kr
Sten Irwe
1.540 %
447,579 1.540 % 2 M kr
Emanuel Eriksson
1.100 %
319,699 1.100 % 1 M kr
Cliens Kapitalförvaltning AB
1.056 %
306,928 1.056 % 1 M kr
Petersen Martin Sokjer
1.030 %
299,355 1.030 % 1 M kr
Axel Schörling
0.8847 %
257,113 0.8847 % 1 M kr
Alexander Brising
0.8827 %
256,543 0.8827 % 1 M kr
Martin Kristoffersson
0.0523 %
15,200 0.0523 % 60 131 kr

Company contact information

EQL Pharma AB

Stortorget 1

222 23, Lund

+46 46 12 01 70

http://www.eqlpharma.com
address EQL Pharma AB(EQL)

Sector

Consumer Non-Cyclicals
Food & Drug Retailing
Food & Drug Retailing
Drug Retailers
Other Drug Retailers

Sales per Business

Sales per region

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Drug Retailers

1st Jan change Capi.
EQL PHARMA AB Stock EQL Pharma AB
+29.64% 115M
JD HEALTH INTERNATIONAL INC. Stock JD Health International Inc.
-31.97% 10.84B
YIFENG PHARMACY CHAIN CO., LTD. Stock Yifeng Pharmacy Chain Co., Ltd.
+8.14% 6.04B
MATSUKIYOCOCOKARA & CO. Stock MatsukiyoCocokara & Co.
-11.41% 5.86B
ALIBABA HEALTH INFORMATION TECHNOLOGY LIMITED Stock Alibaba Health Information Technology Limited
-30.42% 6.06B
NAHDI MEDICAL COMPANY Stock Nahdi Medical Company
-0.88% 4.71B
CORPORATIVO FRAGUA, S.A.B. DE C.V. Stock Corporativo Fragua, S.A.B. de C.V.
+52.19% 4.29B
CLICKS GROUP LIMITED Stock Clicks Group Limited
-12.31% 3.61B
DASHENLIN PHARMACEUTICAL GROUP CO., LTD. Stock DaShenLin Pharmaceutical Group Co., Ltd.
-14.86% 3.33B
WELCIA HOLDINGS CO., LTD. Stock Welcia Holdings Co., Ltd.
-6.93% 3.01B
Other Drug Retailers
  1. Stock Market
  2. Equities
  3. EQL Stock
  4. Company EQL Pharma AB